By Marilynn LarkinNEW YORK (Reuters Health) - Non-manifesting carriers of LRRK2 and GBA mutations may exhibit subtle symptoms suggesting an increased risk for developing Parkinson's disease (PD), a cross-sectional analysis suggests.
By Marilynn LarkinNEW YORK (Reuters Health) - Two stellate ganglion block (SGB) treatments two weeks apart reduced posttraumatic stress disorder (PTSD) symptoms in a multisite randomized clinical trial of US veterans.
Healthy older adults demonstrated higher accuracy of symbol comprehension compared with older adults with major depressive disorder, mild cognitive impairment, or Alzheimer disease dementia, a recent study found.
By Reuters Staff(Reuters) - A panel of experts to the U.S. Food and Drug Administration recommended allowing Amarin Corp Plc's fish-oil derived drug to be used as an add-on therapy for reducing the chance of heart attack and stroke in high-risk patients with cardiovascular disease.
In a bipartisan effort, both democratic and republican representatives issued a series of letters to CMS urging the agency to alter its proposed radiation oncology advanced alternative payment model that is expected to be finalized before the new year.